Korro Bio (KRRO) Treasury Shares (2018 - 2026)

Korro Bio's (KRRO) quarterly Treasury Shares came in at $506174.0 in Q1 2026, little changed on a QoQ basis from $506981.0 in Q4 2025.

Korro Bio (KRRO) Treasury Shares (2018 - 2026) Analysis & Trends

Korro Bio (KRRO) has 8 years of Treasury Shares data on file, last reported at $506174.0 in Q1 2026.

Quarterly Treasury Shares changed N/A year-over-year to $506174.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $506174.0 (changed N/A YoY) and the FY2025 annual result came in at $506981.0, changed N/A from the prior year.
Treasury Shares held at $506174.0 in Q1 2026, from $506981.0 in the prior quarter.
In the past five years, Treasury Shares ranged from a high of $3.6 million in Q1 2023 to a low of $2902.0 in Q4 2022.
A 4-year average of $1.9 million and a median of $2.2 million in 2022 frame the typical range for Treasury Shares.
The widest YoY moves for Treasury Shares: up 106389.61% in 2022, down 99.54% in 2022.
Tracing KRRO's Treasury Shares over 4 years: stood at $2902.0 in 2022, then jumped by 66411.03% to $1.9 million in 2023, then plunged by 73.73% to $506981.0 in 2025, then fell by 0.16% to $506174.0 in 2026.
The last three Treasury Shares figures came in at $506174.0 (Q1 2026), $506981.0 (Q4 2025), and $1.9 million (Q3 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	8.96 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	2.72 Mn
10	Korro Bio	231.77 Mn	116.73 Mn	-	-

Download Data